About CONMED Corporation
https://www.conmed.comCONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.
CEO
Patrick J. Beyer
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2001-09-10 | Forward | 3:2 |
| 1995-12-01 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 180
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Piper Sandler
Overweight
Wells Fargo
Equal Weight
B of A Securities
Neutral
JP Morgan
Neutral
Needham
Hold
Stifel
Hold
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:4.99M
Value:$207.66M
BLACKROCK, INC.
Shares:4.64M
Value:$193.11M
VANGUARD GROUP INC
Shares:3.61M
Value:$150.14M
Summary
Showing Top 3 of 369
About CONMED Corporation
https://www.conmed.comCONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $337.93M ▼ | $154.24M ▲ | $2.86M ▼ | 0.85% ▼ | $0.09 ▼ | $30.49M ▼ |
| Q2-2025 | $342.35M ▲ | $150.16M ▼ | $21.42M ▲ | 6.26% ▲ | $0.69 ▲ | $56.31M ▲ |
| Q1-2025 | $321.26M ▼ | $161.79M ▲ | $6.04M ▼ | 1.88% ▼ | $0.19 ▼ | $34.21M ▼ |
| Q4-2024 | $345.94M ▲ | $145.84M ▲ | $33.76M ▼ | 9.76% ▼ | $1.09 ▼ | $70.5M ▼ |
| Q3-2024 | $316.7M | $113.29M | $48.98M | 15.47% | $1.59 | $83.68M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $38.93M ▲ | $2.32B ▼ | $1.31B ▼ | $1.01B ▲ |
| Q2-2025 | $33.94M ▼ | $2.33B ▲ | $1.33B ▲ | $1B ▲ |
| Q1-2025 | $35.48M ▲ | $2.3B ▼ | $1.32B ▼ | $977.64M ▲ |
| Q4-2024 | $24.46M ▼ | $2.31B ▼ | $1.34B ▼ | $962.68M ▲ |
| Q3-2024 | $38.47M | $2.32B | $1.38B | $932.9M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $2.86M ▼ | $53.69M ▲ | $-5.19M ▲ | $-43.52M ▼ | $4.99M ▲ | $48.5M ▲ |
| Q2-2025 | $21.42M ▲ | $29.13M ▼ | $-5.73M ▼ | $-26.53M ▲ | $-1.55M ▼ | $23.41M ▼ |
| Q1-2025 | $6.04M ▼ | $41.53M ▼ | $-2.93M ▲ | $-28.4M ▲ | $11.03M ▲ | $37.76M ▼ |
| Q4-2024 | $33.75M ▼ | $43.34M ▼ | $-4.04M ▼ | $-51.07M ▼ | $-14.01M ▼ | $39.3M ▼ |
| Q3-2024 | $48.98M | $51.2M | $-3.42M | $-38.83M | $9.6M | $47.78M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 General Surgery | $210.00M ▲ | $180.00M ▼ | $200.00M ▲ | $200.00M ▲ |
 Orthopedic Surgery | $140.00M ▲ | $140.00M ▲ | $140.00M ▲ | $140.00M ▲ |
Revenue by Geography
| Region | Q4-2024 | Q1-2025 | Q3-2025 | Q2-2025 |
|---|---|---|---|---|
 Americas excluding the United States | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ | $30.00M ▲ |
 Asia Pacific | $50.00M ▲ | $40.00M ▼ | $50.00M ▲ | $50.00M ▲ |
 EMEA | $60.00M ▲ | $60.00M ▲ | $60.00M ▲ | $70.00M ▲ |
 UNITED STATES | $200.00M ▲ | $180.00M ▼ | $190.00M ▲ | $190.00M ▲ |
CEO
Patrick J. Beyer
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2001-09-10 | Forward | 3:2 |
| 1995-12-01 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 180
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Piper Sandler
Overweight
Wells Fargo
Equal Weight
B of A Securities
Neutral
JP Morgan
Neutral
Needham
Hold
Stifel
Hold
Grade Summary
Showing Top 6 of 6
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:4.99M
Value:$207.66M
BLACKROCK, INC.
Shares:4.64M
Value:$193.11M
VANGUARD GROUP INC
Shares:3.61M
Value:$150.14M
Summary
Showing Top 3 of 369